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Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USAa; Department of Ophthalmology and Visual
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ABSTRACT
The interferon (IFN) response to viral pathogens is critical for host survival. In humans andmouse models, defects in IFN re-
sponses can result in lethal herpes simplex virus 1 (HSV-1) infections, usually from encephalitis. Although rare, HSV-1 can also
cause fulminant hepatic failure, which is often fatal. Although herpes simplex encephalitis has been extensively studied, HSV-1
generalized infections and subsequent acute liver failure are less well understood.We previously demonstrated that IFN-
R/mice are exquisitely susceptible to liver infection following corneal infection with HSV-1. In this study, we used bone
marrow chimeras of IFN-R/ (AG129) and wild-type (WT; 129SvEv) mice to probe the underlying IFN-dependent mecha-
nisms that control HSV-1 pathogenesis. After infection, WTmice with either IFN-R/ orWTmarrow exhibited compara-
ble survival, while IFN-R/mice withWTmarrow had a significant survival advantage over their counterparts with IFN-
R/marrow. Furthermore, using bioluminescent imaging to maximize data acquisition, we showed that the transfer of
IFN-competent hematopoietic cells controlled HSV-1 replication and damage in the livers of IFN-R/mice. Consistent
with this, the inability of IFN-R/ immune cells to control liver infection in IFN-R/mice manifested as profoundly
elevated aspartate transaminase (AST) and alanine transaminase (ALT) levels, indicative of severe liver damage. In contrast,
IFN-R/mice receivingWTmarrow exhibited only modest elevations of AST and ALT levels. These studies indicate that
IFN responsiveness of the immune system is a major determinant of viral tropism and damage during visceral HSV infections.
IMPORTANCE
Herpes simplex virus 1 (HSV-1) infection is an incurable viral infection with the most significant morbidity andmortality occur-
ring in neonates and patients with compromised immune systems. Severe pathologies fromHSV include the blindness-inducing
herpetic stromal keratitis, highly debilitating and lethal herpes simplex encephalitis, and generalized infections that can lead to
herpes simplex virus-induced acute liver failure. While immune compromise is a known factor, the precise mechanisms that lead
to generalized HSV infections are unknown. In this study, we used and developed a mouse model system in combination with
real-time bioluminescence imaging to demonstrate the relative importance of the immune and nonimmune compartments for
containing viral spread and promoting host survival after corneal infection. Our results shed light on the pathogenesis of HSV
infections that lead to generalized infection and acute liver failure.
Herpes simplex virus 1 (HSV-1) is an enveloped DNA virus anda member of the Alphaherpesvirus subfamily with high sero-
prevalence in the human population (1). In most cases, HSV-1
causes relatively mild orolabial cold sores, but it can cause more
serious localized diseases such herpes stromal keratitis, the leading
cause of infectious blindness in the United States (2, 3). Serious
sequelae for HSV-1 are more common in immunocompromised
hosts and neonates, with uncontrolled viral replication leading to
herpes simplex encephalitis (HSE) or, more rarely, HSV sepsis
leading to acute liver failure (4, 5). HSV-induced acute liver failure
(ALF) is an alarmingly deadly disease with a lethality rate ap-
proaching 75% (5). The importance of studying HSV-induced
ALF is underscored by the immunocompromised populations it
affects, mainly patients undergoing chemotherapy, bone marrow
transplant recipients, HIV patients, and women in the third tri-
mester of pregnancy (5, 6). HSV-1 infects via the mucosae of the
mouth, eyes, or genitalia, where it undergoes lytic replication in
the epithelium (7). During infection of these mucosae, the virus
infects innervating sensory neurons, traveling in a retrograde di-
rection in the facial neurons back to mostly sensory ganglia,
wherein HSV-1 establishes latency (8). The ability of HSV to es-
tablish latency in neurons, a nondividing cell population, hinders
the ability of the immune system to fully clear the virus and ren-
ders the virus refractory to cure with antiviral treatments (9). Im-
mune dysregulation and other stimuli cause HSV-1 to erupt from
latency, traveling anterograde to the mucosal surface, where lytic
replication occurs, often with shedding and infection of a new host
(10).
Interferon (IFN) pathways are critical to an effective response
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to viral infections (11, 12). Upon sensing a viral pathogen-associ-
ated molecular pattern (PAMP), activation and nuclear translo-
cation of the transcription factors IRF3 and IRF7 lead to the ex-
pression of IFNs (13–15). Secreted IFNs act in both a paracrine
and an autocrine fashion, interacting with IFN receptors on the
cell surface, which then upregulates IFN-stimulated genes to in-
duce the antiviral state (11, 12). Type I ( and ) and type II ()
IFNs signal infected and bystander cells to upregulate the innate
antiviral state and prime the adaptive response for viral clearance
(12, 16). Following HSV-1 infection, humans and model hosts
with defects in IFN signaling pathways are unable to control viral
replication (17–19). In this scenario, encephalitis and systemic
HSV-1 infections often follow, which can also lead to acute liver
infection and failure (5, 20). Case reports of HSV-1-induced acute
liver failure indicate that while this presentation is relatively un-
common, it has a remarkably high fatality rate, and there is very
little research on this presentation of HSV-1 (5, 21, 22).
The immune factors that control HSV-1 tropism during gen-
eralized infections are largely unknown. While certain immuno-
deficient mice succumb rapidly to encephalitis via neurotropic
HSV spread, others exhibit a more generalized viscerotropic pat-
tern with particular involvement of the liver (23, 24). In particular,
IFN-R/ mice succumb quickly and synchronously to
HSV-1, with extremely high titers in the liver (24). Consistent
with this, lacking the DNA-binding domain of Stat1, these mice
essentially phenocopy IFN-R/ with high viral loads in the
liver (24). In contrast, among mice lacking the N-terminal do-
main of Stat1, which exhibit a residual low-level Stat1 activity,
liver infection is well controlled, and these animals succumb in-
stead to encephalitis (24, 25). Similarly, IFN-R/mice exhibit
only transient infection of the liver, whereas IFN-R/ mice
show no liver infection (26). These findings underscore the im-
portance of the IFN signaling pathway for control of disseminated
infection. In mice and humans, a variety of mutations in the TLR3
signaling pathway (IRF-3, TYK2, MAVS, TRIF, TBK1, UNC93B1,
IPS-1, and Stat1) are important for protection against HSE (19,
20, 27, 28). Other factors in the IFN pathway, such as the DNA-
sensing pathway adaptor STING (23), appear to be less critical for
protection from HSE following corneal infection. Together, the
multitude of IFN pathway sensors and adaptors allows for tempo-
ral and metered immune responses to pathogens in a variety of
tissues.
Although many components of the IFN pathway are required
for protection from HSE, host factors that control generalized
HSV-1 infection and hepatitis are less well understood. To begin
to address these factors, we performed experiments to determine
the compartment in which IFN responses were most critical for
protection. In particular, we examined whether the IFN responses
of infected tissues were alone protective and examined whether
IFN responses of infiltrating immune cells were critical to the
control of systemic infection. To examine this, we used the IFN-
R/mouse, which is highly sensitive to disseminated HSV-1
and a suitable model for studying viscerotropic infection (24, 29).
We therefore created bone marrow chimeric mice using 129SvEv
(WT) and AG129 (IFN-R/) strains. We utilized biolumi-
nescent HSV strains with IVIS imaging to maximize data collec-
tion from these chimeric mice, which take many weeks to engraft
and are labor-intensive to create (30–32). We show that the non-
immune tissue IFN responses of the mice were largely responsible
for protection from both HSE and acute liver failure. Further-
more, in the context of susceptible IFN-R/mice, the acqui-
sition of an IFN-competent immune compartment was sufficient
to control viral replication and mitigate liver disease, with little
impact on HSE. Together, these data demonstrate the utility of
combining bioluminescent imaging (BLI) and bone marrow chi-
meric mouse approaches, and show that IFN responses in the
nonimmune and immune compartments play distinct roles in
defining the pathogenesis of generalized HSV infections.
MATERIALS AND METHODS
Viruses, cells, and mice. Vero cells were used to propagate viruses and
to determine their titers as described previously (33). The HSV-1
strain used in this study was KOS (34). The luciferase expressing KOS/
Dlux/OriL strain of HSV-1 was used for BLI experiments, as previously
described (31). WT (Taconic, Germantown, NY) and IFN- recep-
tor knockout (IFN-R/) mice were derived from a 129SvEv
background (35).
Bone marrow chimeras. Bone marrow chimeras were created by
irradiating WT (CD45.2-positive) and IFN-R/ (CD45.1-posi-
tive) mice with two 700-Gy doses of gamma radiation with 4 h between
doses. These mice were then reconstituted with 3  106 bone marrow
cells, injected retro-orbitally. The bone marrow cells were given a min-
imum of 8 weeks to reconstitute the bone marrow compartment of
chimeric mice. For control chimeric mice, we created WT¡WT or IFN-
R/¡IFN-R/ chimeras reconstituted with bone marrow
that matched their genotype and sex. Circulating leukocytes were ana-
lyzed by flow cytometry for CD45.1 and CD45.2, and only mice contain-
ing85% desired chimerism were used.
Animal infection and organ harvest. All animals were housed and
treated according to our approved IACUC protocol (Dartmouth protocol
leib.da.1#2) and Federal regulations. Prior to corneal infection mice were
anesthetized with an intraperitoneal (i.p.) injection of a mixture of ket-
amine (87 mg/kg) and xylazine (13 mg/kg). Corneas were scarified in a
1010 crosshatch pattern with a 25-gauge needle and then inoculated
with 2  106 PFU per eye in 5 l of inoculation medium (Dulbecco
modified Eagle medium [HyClone] with 2% fetal bovine serum, a final
concentration of 60 U/ml penicillin [HyClone], and a final concentration
of 60 g/ml streptomycin [HyClone]) (33).
Mice were sacrificed at the specified times postinfection or once they
met endpoint criteria, as defined by our approved IACUC protocol. Eye
swabs were collected at the indicated time points, as previously described
(36). Blood was harvested in heparin-treated tubes, and serum was sepa-
rated by centrifugation at 5,000 g for 5 min and then stored at80°C.
Eye swabs, spleens, livers, brains, brain stems, and trigeminal ganglia were
frozen in the appropriate volume of inoculation medium at80°C. Tis-
sues were prepared for titering by homogenization/disruption with glass
beads and sonication, as previously described (33).
Multiplex cytokine quantification. Cytokines were quantified by us-
ing a bead-based multiplex protocol as previously described (25). Serum
was harvested at the days postinfection indicated and stored at 80°C
until processing. Serum was diluted by an equal volume of Bio-Rad serum
diluent solution (Bio-Rad, Hercules, CA). A Bradford assay was used to
normalize protein levels. A BioPlex bead-based multiplex cytokine quan-
tification kit was used according to the manufacturer’s instructions (Bio-
Rad). All cytokine concentrations were quantified by comparison to a
standard curve. A minimum of four mice were used for each data point on
each day postinfection.
Organ histology. Mice were sacrificed at the indicated days postin-
fection, organs harvested, and fixed in 10% neutral buffered formalin.
These were then paraffin embedded, sectioned, and stained with he-
matoxylin and eosin by the pathology core facility at Dartmouth-
Hitchcock Medical Center (Lebanon, NH). The slides were coded to
conceal the treatment group and then assessed for pathology in a
masked fashion.
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Bioluminescent imaging (BLI). Mice were infected corneally with
KOS/Dlux/OriL and injected i.p. at the appropriate times postinfection
with filter-sterilized D-luciferin potassium salt (Gold Biotech, St. Louis,
MO) in phosphate-buffered saline (PBS) at 150 mg/kg. Mice were anes-
thetized with 2.5% isoflurane and imaged using a cooled charge-coupled
device camera equipped instrument (IVIS 100; Caliper Life Sciences,
Hopkinton, MA) as previously described (30). Imaging parameters
(f-stop, binning, shutter speed, field of view, and scales) were all kept
consistent when comparing images, as described in the figure legends.
When quantifying the photon signal, the same region of interest (ROI)
was placed on each mouse, and the total flux of photons per second was
recorded for analysis. All images were analyzed using Igor Pro Living
Image software (v2.60; Perkin-Elmer, Akron, OH).
Liver enzyme quantification. Sera were processed by centrifuging
heparin-treated blood samples at 5,000  g for 5 min at 4°C. Aspartate
aminotransferase (AST) and alanine transaminase (ALT) were quantified
on a Roche Cobas c500 analyzer (Roche Holding AG, Basel, Switzerland).
ALT was quantified by using an in vitro test for the quantitative determi-
nation of the catalytic activity of ALT (ALTL kit; Roche). AST was quan-
tified by using an in vitro test for the quantitative determination of the
catalytic activity of AST (ASTL kit; Roche.
Evans blue uptake to measure blood-brain barrier (BBB) permea-
bility. Evans blue uptake experiments were carried out as previously de-
scribed (25). At 1 h prior to sacrifice, the mice were injected i.p. with 300
l of 2% (wt/vol) Evans blue dye in PBS. Upon sacrifice, the mice were
perfused with a minimum of 50 ml of PBS, and the brains were harvested
into 1 ml of PBS. These samples were then homogenized with a tissue
homogenizer (Omni International, Kennesaw, GA); 1 ml of 100% (wt/
vol) trichloroacetic acid was added, and the samples were mixed and then
incubated on ice for 30 min. The samples were centrifuged at 2,800 g for
30 min at 4°C, and the supernatant optical density was quantified at 620
nm using a Bio-Rad (Hercules, CA) iMark plate reader. Increased dye
concentration in the brain correlates with increased blood-brain barrier
permeability.
RESULTS
The WT IFN response of immune cells confers survival advan-
tage in IFN-R/mice following HSV-1 corneal infection.
Previous studies have shown that IFN-R/mice quickly suc-
cumb to corneal HSV-1 infection (5 dpi). We sought to assess
the contribution of IFN responses of the immune compart-
ment relative to the IFN responses of the nonimmune com-
partment in the control of generalized infections. To accom-
plish this, we created IFN-R/ and wild-type (WT) bone
marrow chimeric mice (24, 29). We generated WT mice recon-
stituted with WT bone marrow (WT¡WT), WT with IFN-
R/ marrow (R/¡WT), R/ mice with WT
marrow (WT¡R/), or IFN-R/ mice reconstituted
with IFN-R/ marrow (R/¡R/) (Fig. 1A).
Mice were corneally infected with 2 106 PFU/eye HSV-1 strain
KOS and observed for 21 days postinfection (dpi) or until end-
point health criteria were met (Fig. 1B). Interestingly, the
WT¡R/ mice survived significantly longer than the
R/¡R/ mice, suggesting that IFN responses of
bone marrow-derived cells are protective during HSV infection of
IFN-defective hosts. Despite this survival advantage, both
WT¡R/ and R/¡R/ mice reached end-
point criteria by 8 dpi. Furthermore, both WT¡WT and
R/¡WT mice survived the full 21 days of the study.
Together, these results suggest the IFN responses of the tissues
are more critical for protection from generalized infection than
IFN responses of the infiltrating immune cells from the bone
marrow.
Thewild-type IFN response of circulating immune cells con-
trols viral dissemination in IFN-R/mice.To examine the
tropism of HSV-1 in the chimeric mice, we infected them with
luciferase-expressing HSV-1 KOS/Dlux/OriL (KOSDlux) and im-
aged spread of the virus in using real-time BLI. The use of BLI
allowed us to examine the spread of HSV in real time without the
need to sacrifice mice prior to reaching the endpoint criteria,
thereby extending the data obtained from these valuable chimeric
mice (30, 32). Mice were infected via the cornea with KOSDlux
virus at 2 106 PFU/eye and imaged at 3, 5, 7, and 9 dpi. In these
experiments, R/¡R/ mice reached the endpoint
criteria at day 5, whereas WT¡R/ mice reached the end-
point at 9 dpi due to a slight reduction in virulence of the KOSD-
lux virus. Although R/¡R/ mice emitted an in-
tense photon flux, mainly originating in the region of the liver at 5
dpi, the WT¡R/ mice had significantly fewer photons
emitting from the liver area at day 5 dpi, and this signal was at
background levels by 9 dpi (Fig. 2A). Neither WT¡WT mice nor
R/¡WT mice had disseminated virus, although the
FIG 1 Percent chimerism and survival of chimeric mice following corneal infection. (A) Irradiated bone marrow recipient mice were reconstituted with desired
bone marrow and confirmed using flow cytometry of CD45.1 or CD45.2 congenic markers. Mice at less than an 85% desired engraftment were not used for
experiments. Data are from two representative independent chimera engraftments with9 mice per group. (B) Mice were infected with 2 106 PFU/eye HSV-1
strain KOS and monitored for 21 days or until endpoint criteria were met. ***, P	 0.0005. Statistical significance was determined by a Mantel-Cox test, with two
independent experiments with6 mice total per group.
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R/¡WT mice demonstrated increased signal originating
at the cervical lymph nodes relative to the WT¡WT mice. Quan-
tification of ventral bioluminescence was achieved through re-
gion-of-interest (ROI) analysis on the ventral abdominal area of
the mice (Fig. 2B). ROI analysis revealed the highest flux from the
R/¡R/mice, an observation consistent with previ-
ous data (24). Ventral bioluminescence in WT¡R/ mice
increased by 5 dpi but, surprisingly, returned to baseline levels by
7 dpi. This suggested that the virus was being controlled in the
liver in these mice in an IFN-competent hematopoietic cell-de-
pendent manner. Accordingly, both the WT¡WT mice and the
R/¡WT mice had ventral bioluminescent signals at
baseline throughout the experiments. To confirm which organs
had the greatest bioluminescent signal at the experimental end-
points of 5 and 9 dpi, organs were harvested, and ex vivo BLI
was performed. The signal from R/¡R/ mice
was saturating (Fig. 3A), and a shorter exposure was therefore
performed for organs at 5 dpi to more accurately measure the
very high signal from these livers (Fig. 3B). This ex vivo BLI
showed that the highest photon flux was from the livers of
FIG 2 BLI and quantification of HSV-1 (KOSDlux) in chimeric mice following corneal infection. (A) BLI of WT¡WT, R/¡WT, WT¡R/, and
R/¡R/ mice infected with 2 106 PFU of KOSDlux per eye. The photon flux heatmap is set to a log scale with a minimum of 5 104 photons
(p)/s/cm2/sr (purple) and a maximum of 5  107 p/s/cm2/sr (red). (B) Total photon flux from abdomens of mice quantified using region of interest (ROI)
analysis using Living Image software (Xenogen). ***, P	 0.0005. Statistical analysis was performed using an unpaired two-tailed t test. Results are from three
independent experiments with8 mice per group.
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R/¡R/ mice, with high signals also seen in the
spleens and trigeminal ganglia, and a low signal from the brain
stems. Little signal was seen with any of the 9-dpi mice com-
pared to the 5-dpi R/¡R/ mice. Substantial BLI
was also seen in the brains and trigeminal ganglia at 9 dpi with
bothR/¡WT and WT¡R/mice. The photon flux
appeared to be greater in the brains of WT¡R/ mice at 9
dpi, suggesting reduced viral control in these mice. Both chimeras,
however, have demonstrated IFN deficiencies in either the hema-
topoietic or the nonhematopoietic compartment that allow
greater viral replication in the brain and central nervous system
(CNS).
FIG 3 (A) Ex vivo BLI of brain (B), trigeminal ganglia (TG), liver (L), and spleen (S) of chimeric mice on terminal experimental time point (9 dpi for
WT¡WT, R/¡WT, WT¡R/, and 5 dpi for R/¡R/). The photon flux heatmap is set to a log scale with a minimum of
3.9  104 photons (p)/s/cm2/sr (purple) and a maximum of 7.5  106 p/s/cm2/sr (red). (B) The same ex vivo organs from panel A at 5 dpi, but the
luminescence was acquired using a shorter exposure and the image heatmap scale has a minimum of 1.54  106 p/s/cm2/sr (purple) and a maximum of
1.73 108 p/s/cm2/sr. (C) BBB permeability quantification using Evans blue after infection with HSV-1 (KOS) at 2 106 PFU/eye in mice at 7 dpi, except
for R/¡R/mice, which were sacrificed at 5 dpi. BBB permeability was quantified using Evans blue dye absorbance from perfused mice brain
homogenates. *, P	 0.05 (statistical analysis was performed using an unpaired two-tailed t test between columns). The results are from two independent
experiments with 5 mice per group.
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Although both WT¡R/ and R/¡R/
mice succumbed to corneal infection with HSV-1 regardless of the
IFN competence of their immune systems, the presence of WT
immune cells in WT¡R/ mice spared them from fulmi-
nant infection involving the liver. To examine this further, we
injected mice with Evans blue dye, which only enters the CNS
where there is a breach of the BBB, as happens often during
encephalitis (25, 37). Evans blue dye was administered to the
chimeric mice, and the absorbance of brain homogenates was
quantified (Fig. 3C). All mice were sacrificed at 7 dpi, with the
exception of IFN-R/ mice, which had to be sacrificed on
5 dpi since they met the endpoint criteria. As judged by Evans
blue quantification, the BBB permeability of WT¡WT or
R/¡WT mice was comparably low. In contrast, the BBB
permeability of WT¡R/ and R/¡R/ mice
was elevated to similar levels, suggesting that IFN-R/
brains cannot be protected by the IFN response of the immune
compartment.
IFN responses of infected tissues are pivotal for control of
viral replication. To further quantify the replication of HSV-1
in different tissues, we infected mice via the cornea with HSV-1
KOS at 2 106 PFU/eye and determined the viral titers (Fig. 4).
In the eyes of R/¡R/ mice, viral replication was
100-fold higher than in WT¡R/ mice at both 3 and 5
dpi (Fig. 4A). This suggests that the IFN responses of WT in-
filtrating immune cells are important for the control of viral
replication in the cornea (Fig. 4A). Further supporting this
hypothesis, we observed higher viral titers in the eyes of
R/¡WT mice compared to WT¡WT mice at 7 dpi.
Furthermore, in contrast to the WT¡WT mice, in which virus
was undetectable in the cornea by 9 dpi, the R/¡WT mice
failed to clear virus, with 104 PFU/ml persisting therein. Viral
replication was also more pronounced in the trigeminal ganglia of
WT¡R/ and R/¡R/ mice compared to
R/¡WT or WT¡WT mice (Fig. 4B). Virus was cleared
from the ganglia of bothR/¡WT and WT¡WT mice, and
latency was established (Z. M. Parker and D. A. Leib, unpublished
data). This suggests a lack of control of viral replication in the
IFN-deficient nervous system, regardless of the immune cell IFN
competence. Similar patterns were also observed in the brain stem
and the brain (Fig. 4C and D). Unexpectedly, however, there was
a stark contrast at 5 dpi in which viral titers were 10,000-fold
higher in the livers of R/¡R/ mice compared to
WT¡R/ mice (Fig. 4E). Viral titers in the spleen and se-
rum were also highest in R/¡R/ mice at 5 dpi rel-
ative to the other chimeras (Fig. 4F and G). Taken together, these
findings suggest that the IFN responsiveness of immune cells is
necessary for the efficient clearance of virus from most tissues.
Nonetheless, the IFN responsiveness of the host tissues is capable
of controlling viral replication to the extent that the host does not
succumb to infection, regardless of the IFN receptor status of in-
filtrating immune cells.
IFN-competent circulating immune cells protect IFN-
R/ mice from HSV-1-induced acute liver failure. Previ-
ous studies have shown that certain IFN-deficient mice (IFN-
R/, Stat1/) exhibit increased susceptibility to HSV liver
infection (24, 26, 29). In the present study, we observed a reduced
viral burden in the livers of WT¡R/ mice relative to
R/¡R/ mice (Fig. 2 and 4E). We therefore hy-
pothesized that the reduced viral burden resulting from these
circulating WT immune cells would protect the liver from
damage. We therefore quantified the levels of circulating aspar-
tate aminotransferase (AST) and alanine transaminase (ALT),
which, when elevated, are diagnostic for liver damage (Fig. 5A
and B). The normal levels of AST and ALT are 
60 and 
28
IU/liter, respectively (38). In acute viral hepatitis, AST and
ALT levels can rise to between 300 and 3,000 IU/liter. In cases
of severe toxicity, such as acetaminophen overdose or isch-
emia, AST and ALT concentrations increase to levels ranging
from 500 IU/liter up to 10,000 IU/liter. As expected, WT¡WT
and R/¡WT mice showed no significant changes in se-
rum AST or ALT throughout infection (Fig. 5A and B). In
contrast, at 5 dpi both AST and ALT in R/¡R/
mice were at the critically high levels of 
22,000 and 
12,000
IU/liter, respectively. This suggests that R/¡R/
mice undergo acute liver damage by 5 dpi. Interestingly,
WT¡R/ mice showed peak AST and ALT levels of 
700
and 
450 IU/liter, respectively, by 7 dpi. While certainly ele-
vated, these liver enzyme peaks are muted relative to those seen
in R/¡R/ mice, suggesting that the IFN respon-
siveness of the immune compartment protects the liver from
damage.
To confirm and extend our AST/ALT studies, we performed
histology examinations on the livers of infected chimeric mice
(Fig. 5C to H). Mice were infected with KOS at 2  106 PFU/eye
and sacrificed at 5 or 7 dpi. Hematoxylin-eosin-stained sections
were examined in a masked fashion to assess the pathology in the
livers of chimeric mice. In WT¡WT mice at 7 dpi, the livers
showed mild infiltration of lymphocytes and neutrophils and oc-
casional apoptotic cells (indicated by an arrow), but these livers
were relatively healthy (Fig. 5C). In R/¡WT mice at 7 dpi
there were slightly more foci of infiltrating lymphocytes and neu-
trophils compared to the WT¡WT mice (Fig. 5D). In contrast to
the relatively undamaged WT¡WT and R/¡WT livers,
WT¡R/ livers showed multifocal necrosis and greater
numbers of infiltrating inflammatory cells (indicated by arrows
Fig. 5E and F). There are infiltrating lymphocytes and neutro-
phils into an area of hepatic necrosis (Fig. 5F). The most severe
liver pathology was in R/¡R/ mice at 5 dpi in
which extensive necrosis was observed (Fig. 5G and H). A de-
generating hepatocyte with nuclear accumulations of periph-
eralized chromatin can also be seen (arrow in Fig. 5H), suggest-
ing intranuclear viral replication. Overall, the pathology of
these livers was consistent with BLI, titer, and AST/ALT data in
this study.
IFN-R/mice have delayed inflammatory immune re-
sponses. Viral infection and liver damage is often exacerbated
through cytokine storm and immune dysregulation (39–41). Hav-
ing shown that the IFN status of the immune compartment is
critical for controlling generalized infections and liver damage, we
sought to assess whether abnormal cytokine levels were an addi-
tional component in the liver disease observed in IFN-R/
mice. To address this, we took sera from infected WT and IFN-
R/ mice and quantified 23 different cytokines using Bio-
Plex (Fig. 6). At 1 dpi, the cytokine responses of WT mice were
generally higher, especially the proinflammatory cytokines inter-
leukin-1 (IL-1) and tumor necrosis factor alpha (TNF-) (Fig.
6A). By 3 dpi, however, inflammatory cytokine expression in WT
mice had largely subsided (Fig. 6B). In contrast, the IFN-
R/ mice exhibited a muted response by 1 dpi, but by 3 dpi
Parker et al.
10794 jvi.asm.org December 2016 Volume 90 Number 23Journal of Virology
they showed overexpression of many cytokines, especially granu-
locyte colony-stimulating factor (G-CSF), TNF-, gamma inter-
feron (IFN-), and MCP-1. By 5 dpi, the cytokine levels in WT
mice continued to normalize, whereas in IFN-R/mice they
remained persistently high, and certain cytokine levels (especially
IL-6, G-CSF, and IFN-) continued to increase (Fig. 6C). Taken
together, WT mice show a rapid, but controlled inflammatory
cytokine response to infection. In contrast, IFN-R/ mice
show a delayed cytokine response to infection which then pre-
sented as an elevated cytokine profile compared to WT mice, co-
incident with the IFN-R/ mice reaching endpoint criteria
by 5 dpi.
FIG 4 Viral titers in tissues of chimeric mice following corneal infection with HSV-1 (KOS) at 2 106 PFU/eye. Mice sacrificed on days 3, 5, 7, and 9 were
used to collect titer data for eye swabs (A), trigeminal ganglia (B), brain stem (C), brain (D), liver (E), spleen (F), and serum (G). *, P	 0.05; **, P	 0.005;
***, P	 0.0005 (statistical significance was tested using an unpaired two-tailed t test). The results are from four independent experiments with8 mice
per group.
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DISCUSSION
HSV-1 poses a serious risk for patients who are immunocompro-
mised, have congenital defects in the IFN and related pathways, or
have underdeveloped immune responses. While there is a greater
risk for these populations to experience HSE, HSV-induced acute
liver failure has not been widely studied. To protect these at-risk
populations, early administration of antiviral nucleoside analog
drugs is key, but HSV-induced acute liver failure often goes mis-
diagnosed because it is relatively rare, with only
1% of acute liver
failures caused by HSV (5, 21). Although rare, HSV-induced acute
liver failure has a lethality rate of near 75% (5). In the present
study, we have demonstrated that the IFN responsiveness of the
tissues of the host outweigh the control exerted by circulating
immune cells during generalized infection with HSV-1. That said,
IFN responsiveness of the circulating immune cells clearly con-
tributes to controlling generalized infections, particularly in the
liver. The incidence of HSV-induced liver failure is well estab-
lished in the case report literature, with most cases occurring in
immunocompromised patients, although some immunocompe-
tent patients succumb to the disease (21, 42, 43). Although this
disease has gained attention, especially in the transplant literature,
to our knowledge there has been no basic research on HSV hepa-
totropism and the role of innate immunity therein. Most IFN
pathway-deficient mice are highly susceptible to HSV-1, but most
FIG 5 Serum aspartate transaminase (AST) and alanine transaminase (ALT) quantification, and liver histology after corneal infection with HSV-1 (KOS) at 2
106 PFU/eye. Sera from infected mice was collected at 3, 5, and 7 dpi, and then AST (A) and ALT (B) were quantified. (C to G) Hematoxylin-eosin staining of liver
sections of mice at 7 dpi, except forR/¡R/mice, which were sacrificed at 5 dpi when they reached endpoint criteria. (C) Liver of WT¡WT mouse
at 40 objective magnification. Note the mild infiltration of lymphocytes and occasional neutrophils, as well as individual apoptotic cells (arrow). (D) Liver of
R/¡WT mouse using 20 objective magnification. Note the multifocal infiltrates of lymphocytes with occasional neutrophils. (E and F) Liver of a
WT¡R/ mouse at 10 (E) and 20 (F) objective magnifications. In panel E, note the multifocal necrosis with associated mixed inflammatory cell
infiltration (arrows). Panel F is a higher-magnification view of panel E showing mixed lymphocytic and neutrophilic infiltration in an area of hepatic necrosis.
Clear vacuoles in hepatocytes indicate accumulation of neutral lipid associated with metabolic disturbance. (G and H) Liver of a R/¡R/ mouse
at10 (G) and30 (H) objective magnifications. Note the extensive multiple areas of necrosis (arrows in panel G), the large area of hepatocellular necrosis (“N”
in panel H), and peripheralized chromatin (arrow in panel H), suggesting intranuclear viral replication.
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of them succumb to encephalitis (44, 45). A few mouse strains
(IRF3/7/, Stat1 DNA-binding domain/) infected with HSV
exhibit pathogenesis and mortality patterns that are consistent
with liver damage, although liver failure as a cause of death was not
directly examined (15, 24). Interestingly, IFN-R/mice show
robust infection of the liver but clear the virus and survive infec-
tion, whereas IFN-R-deficient mice show no liver infection at all
(26). The results in this study are therefore consistent with synergy
of type I and II IFNs when responding to generalized HSV-1 in-
fection, in accordance with previous studies (46). Indeed, the
presence of IFN-competent immune cells was sufficient to spare
the mice from hepatic failure even when the nonimmune com-
partment was IFN deficient. It appears, therefore, that when IFN-
 responses are completely ablated, the mice present with se-
vere hepatic failure upon infection with HSV-1 (15, 24).
Here, R/¡R/ mice had disseminated viremic
disease and succumbed to acute liver failure. In contrast,
WT¡R/ mice had relatively little liver pathology, al-
though they still showed multiple areas of necrosis at endpoint
criteria. The IFN responses of the circulating immune cells in
WT¡R/ mice largely controlled viral replication in the
liver, thereby reducing damage. Interestingly, this protection of
the liver by IFN-competent immune cells was inadequate to fully
protect the mice which reached endpoint criteria by 7 dpi. The
Evans blue data suggest that the WT¡R/ mice most likely
succumb to encephalitis. The somewhat elevated AST and ALT
levels in these mice may be contributing to the encephalitis read-
out observed (47). It appears, therefore, that in an immunocom-
promised host an IFN-competent immune compartment can
protect the liver but not the brain. Furthermore, in WT¡WT or
IFN-R/¡WT mice, survival was at 100%, and virus titers
were much lower than in WT¡IFN-R/mice, demonstrat-
ing that the tissues and resident cells exert greater control on viral
replication and survival than do circulating immune cells. It is also
interesting that in the corneas of IFN-R/¡WT mice at 9
dpi, virus was not cleared. Consistent with our data, the cornea
relies on both the resident and early infiltrating immune cell re-
sponse for a proper response to HSV-1 (48, 49). Our data add that
the IFN competence of infiltrating immune cells is necessary for
efficient viral clearance in this normally avascular site.
It should be noted that the appearance of HSV in the liver
following ocular infection is not peculiar to infection of IFN-de-
fective mice. We have observed HSV in the livers of WT mice
within hours of initial infection, although this initial systemic in-
fection is rapidly cleared (26; A. J. Charron and D. A. Leib, unpub-
lished data). These findings, together with this study, suggest that
the IFN response is irrelevant to seeding of infection in the liver.
Rather, some source of IFN response is paramount for control of
viral replication and liver damage, as evidenced from patterns of
infection and liver disease observed in this study. That said, there
is likely a role for appropriately regulated cytokine expression in
the prevention of hepatic failure. Indeed, the liver is an immune
privileged organ that is constantly being exposed to a variety of
foreign antigens, and immune response must therefore be care-
FIG 6 Serum cytokines of sera from WT and IFN-R/ mice measured by BioPlex following corneal infection with HSV-1 (KOS) at 2 106 PFU/eye. The
serum cytokines from infected mice were quantified at 1 dpi (A), 3 dpi (B), and 5 dpi (C). The results are from two independent experiments with10 mice per
group.
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fully regulated to avoid collateral damage (50). The liver develops
a robust IFN response to liver-stage Plasmodium in a mouse
model of infection. In this system, using either hepatocyte IFN-
R-deficient or myeloid IFN-R-deficient mice, it was shown
that a primary antiparasitic IFN response was driven almost ex-
clusively by the hepatocytes, whereas the myeloid-derived IFN
responses played a role later in infection (51). Our study therefore
mirrors these findings in showing that IFN responses in the liver
are the primary drivers of antimicrobial responses, while infiltrat-
ing immune cells play a supporting role.
Our finding of circulating cytokines in WT mice following in-
fection shows an early inflammatory response, which is then ap-
propriately downregulated. In IFN-R/ mice, however,
there was a delay in the inflammatory cytokine response and then
an overreaction at later days postinfection. The dysregulation seen
in IFN-R/ mice could be either due to the incapacitated
negative feedback in the IFN-dependent inflammatory pathways,
or it could result from the increased PAMP signal from an increas-
ing viral load. It is most likely that it is a combination of both
factors, and the result of this dysregulated cytokine response is
severe immune pathology. In either case, our study elucidated the
role of compartment-specific IFN responses in virus-induced liver
failure through a unique combination of BLI and bone marrow
chimeric approaches. Understanding these responses and path-
ways will lead to more appropriate interventions in patients with
HSE and HSV acute liver failure, as well as other pathogen-in-
duced liver pathologies (5). The data presented here regarding
IFN responsiveness of the liver give insight into the underlying
cause of disseminated HSV infections.
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